Another Biotech on Tap in the books! Thank you to all attendees who joined us this week at the 5th Annual Biotech on Tap at Oktoberfest. It was an insightful and network filled week in Munich discussing the U.S. and EU markets, M&A, IPOs, Artificial Intelligence, and the Biotech sector. A special shout to our co-host Goodwin as well as our sponsors CFGI, EY, NautaDutilh, and Toppan Merrill. We're in the process of planning Biotech on Tap 2025! If you have any ideas or would like an invitation, please reach out to Thomas Hoffmann, Dirk Gallowsky, or Robert Puopolo. Prost!
H.C. Wainwright & Co., LLC
Banking
Sector-focused #InvestmentBanking , Equity Research, Sales & Trading, Strategic Advisory & Corporate Access Services.
About us
H. C. Wainwright & Co., LLC is a full-service investment bank dedicated to providing Investment Banking, Equity Research, Sales & Trading as well as Corporate Access and Strategic Advisory services. Ranked the #1 Placement Agent by Informa Business Solutions (formerly Sagient Research Systems) since 1998, the H.C. Wainwright team is the leader and most active placement agent of Follow-On transactions. In 2018, H.C. Wainwright celebrates 150 years of innovative service led by a diverse group of seasoned Investment Bankers, thoughtful Equity Research Analysts and insightful Sales-Traders.
- Website
-
https://hcwco.com/
External link for H.C. Wainwright & Co., LLC
- Industry
- Banking
- Company size
- 51-200 employees
- Type
- Privately Held
- Founded
- 1868
Locations
-
Primary
Employees at H.C. Wainwright & Co., LLC
-
Sameer Joshi
Senior Equity Research Analyst; Investment Banking Managing Director: CleanTech, Nuclear, Sustainable, ESG
-
Thomas Hoffmann
Head of Institutional Equities at H.C. Wainwright & Co., LLC
-
Marco Maximilian Elser
Partner LONSIN Capital | Founder Member Operation Smile Italia
-
Morten Marott
Senior Wall Street Investment Banker and Public & Private Biotech CFO
Updates
-
We invite you to join us on October 8th at the 5th Annual Viral Hepatitis Virtual Conference to engage in an in-depth exploration of the various viruses responsible for hepatitis, along with discussions on emerging technologies in the field. Join esteemed industry thought leaders as they share their insights and emerging advancements, contributing to combating viral hepatitis. For more information and registration, visit https://lnkd.in/ehDKx6xJ
-
Join us at our 8th Annual MASH Investor Conference on October 7th to discuss metabolic dysfunction-associated steatohepatitis. The virtual conference will feature experts in gastroenterology, hepatology, and metabolism to discuss latest research, advancements, and clinical strategies regarding #MASH. Don’t miss this opportunity to expand your knowledge and connect with peers! Register here https://lnkd.in/eJkAPSm8
-
Next week, Richard Gormley, Michael E. Meyers, and Thomas Hoffmann will be in Munich, Germany to host our 5th annual Biotech on Tap during Oktoberfest. We are looking forward to connecting with over 150 industry leaders September 25-27th to discuss U.S. and international capital market trends and opportunities through various panels keynote speakers, and networking. If interested in attending, please contact your HCW representative or email [email protected]
-
That’s a wrap on the 2024 HCW Global Investment Conference in New York! We welcomed over 2,000 guests including company executives across various sectors, institutional investors, and keynote speakers and were able to help facilitate over 4,000 meetings. Among the many conversations that occurred over the course of three-days, what was abundantly clear was the excitement for new emerging technologies and advancements across all subsectors. This enthusiasm creates opportunities for capital deployment and strategic partnerships, as market dynamics offer new avenues for growth and value creation. Thank you to all attendees, presenters, panelists, and our sponsors: Baker McKenzie, EisnerAmper, Ellenoff Grossman & Schole LLP, Haynes and Boone, LLP, IRTH Communications, Katten Muchin Rosenman LLP, Lowenstein Sandler LLP, Marcum LLP, and Sheppard Mullin Richter & Hampton LLP. We are immensely grateful for your continued support and contributions to another successful event. We can’t wait for next year! #HCWainwrightGlobal
-
CleanSpark (NASDAQ: CLSK) will be featured on the next HCW @ Home on September 23rd at 4pm ET for a virtual fireside chat. CleanSpark Chief Executive Officer, Zachary Bradford, and Executive Chairman, Matthew Schultz, will be joined by our Research Analyst, Mike Colonnese, for a discussion surrounding the company’s Bitcoin mining operations, growth strategy, recent acquisitions, the M&A landscape, as well as management’s near-term outlook for Bitcoin and the industry. To tune in, please register at https://ct.to/ykz8hN1
-
The 26th Annual Global Investment Conference kicked off with an opening address by our very own, Richard Gormley, Vice Chairman- President of Capital Markets welcoming attendees and providing an update on the Life Sciences capital markets. Over the course of the next three days, more than 500 companies and 2,000 attendees from around the globe will come together to share insights, forge new connections, and explore the future of Life Sciences, Cryptocurrency, Metals & Mining, Technology, Telecommunications, and Cleantech. Today's highlights include: -Implications of New Healthcare Policy Reform on the Pharma/Biotech Industries Panel -Cutting-edge Approaches to Viral Hepatitis: Is a Cure on the Horizon? -Keynote by Vivek Ramaswamy, Former 2024 U.S. Presidential Candidate, New York Times Bestselling Author If you’re in attendance, please connect with us and use the #HCWainwrightGlobal hashtag with conference associated posts! Our team can’t wait to engage with participants. Stay tuned!
-
The countdown has begun! We’re less than one week away from our Annual Global Investment Conference. This year’s event will feature compelling keynote addresses from former U.S. Presidential candidate Vivek Ramaswamy and Michael Saylor, Executive Chairman of MicroStrategy Incorporated. The conference will also showcase a diverse range of panel discussions, including a Bitcoin Mining panel moderated by Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital. For more information and registration, please visit: https://lnkd.in/dVcQVaUE #HCWainwrightGlobal
-
We are excited to announce the expansion of our equity research department with the addition of David Lenchus to the H.C. Wainwright team. David joins us as Managing Director and Director of Equity Research and will continue to strengthen our commitment to providing exceptional insights and top-tier analysis to our clients across various sectors. David brings nearly 20 years of experience in equity research and has a strong track record of building and driving research initiatives as well as expanding reach within the equity markets. Welcome to the team, David!
-
Thank you to all participants who contributed to the resounding success of the 4th Annual Ophthalmology Conference we hosted earlier this month. Our sincere gratitude to our distinguished speakers, dedicated attendees, and enthusiastic presenting companies- your insights, discussions, and networking have sparked new ideas and opportunities that will continue to drive the #Ophthalmology industry forward. For those who missed it, replay links are available below: -The Evolving Therapeutic Landscape of AMD https://lnkd.in/eEfHhmBp -Current Innovations in the Retina—A Conversation With Dr. Arshad Khanani, MD https://lnkd.in/ey64hRvn -Derisked Late-stage Candidates for Retinal Disorders https://lnkd.in/e79iYisM -Gene Therapy In-Focus — A Fireside Discussion on 4D-150 and Beyond With 4D Molecular Therapeutics https://lnkd.in/eAXGhvSN -Novel Approaches for Front-of-the-Eye Indications https://lnkd.in/eqGP2sXA -Gene Therapy In-Focus—A Fireside Discussion on Ixo-vec Progress With Adverum Biotechnologies https://lnkd.in/e8bCZcrP View upcoming HCW events at www.hcwevents.com